Abstract
In the present study we showed that the recombinant analogue of the SLURP-1 protein effectively inhibits the growth of a 3D model of tumors—multicellular spheroids reconstructed from human epidermoid carcinoma A431 cells and human lung adenocarcinoma A549 cells. The combined application of rSLURP-1 with gefitinib (inhibitor of epidermal growth factor receptor (EGFR)) leads to the synergistic antiproliferative effect on spheroids from A431 cells. The results obtained suggest the possibility for design of first-in-class anticancer drugs based on recombinant SLURP-1.
Similar content being viewed by others
REFERENCES
Grando, S.A., Nat. Rev. Cancer, 2014, vol. 14, pp. 419–429. https://doi.org/10.1038/nrc3725
Schaal, C. and Chellappan, S.P., Mol. Cancer Res., 2014, vol. 12, pp. 14–23. https://doi.org/10.1158/1541-7786.MCR-13-0541
Shulepko, M.A., Kul’batskii, D.S., Bychkov, M.L., et al., Bioorg. Khim., 2019, vol. 45, no. 3, pp. 227–237. https://doi.org/10.1134/S1068162019020122
Russo, P., Cardinale, A., Margaritora, S., et al., Life Sci., 2012, vol. 91, pp. 1087–1092. https://doi.org/10.1016/j.lfs.2012.05.003
Grozio, A., Paleari, L., Catassi, A., et al., Int. J. Cancer, 2008, vol. 122, pp. 1911–1915. https://doi.org/10.1002/ijc.23298
Vasil'eva, N.A., Loktyushov, E.V., Bychkov, M.L., et al., Usp. Biol. Khim., 2017, vol. 57, pp.303–330. https://doi.org/10.1134/S0006297917130090
Bergqvist, C., Kadara, H., Hamie, L., et al., Int. J. Dermatol., 2018, vol. 57, pp. 162–170. https://doi.org/10.1111/ijd.13850
Pettersson, A., Nylund, G., Khorram-Manesh, A., et al., Auton. Neurosci. Basic Clin., 2009, vol. 148, pp. 97–100. https://doi.org/10.1016/j.autneu.2009.03.002
Russo, P., Cardinale, A., Margaritora, S., et al., Life Sci., 2012, vol. 91, pp. 1087–1092. https://doi.org/10.1016/j.lfs.2012.05.003
Arredondo, J., Chernyavsky, A.I., and Grando, S.A., Life Sci., 2007, vol. 80, pp. 2243–2247. https://doi.org/10.1016/j.lfs.2007.01.003
Kalantari-Dehaghi, M., Bernard, H.-U., and Grando, S.A., Life Sci., 2012, vol. 91, pp. 1122–1125. https://doi.org/10.1016/j.lfs.2012.02.004
Throm, V.M., Mannle, D., Giese, T., et al., Oncotarget, 2018, vol. 9, pp. 11734–11751. https://doi.org/10.18632/oncotarget.24312
Lyukmanova, E.N., Shulepko, M.A., Kudryavtsev, D., et al., PLoS One, 2016, vol. 11. e0149733. https://doi.org/10.1371/journal.pone.0149733
Lyukmanova, E., Bychkov, M., Sharonov, G., et al., Br. J. Pharmacol., 2018, vol. 175, pp. 1973–1986. https://doi.org/10.1111/bph.14194
Riedl, A., Schlederer, M., Pudelko, K., et al., J. Cell Sci., 2017, vol. 130, pp. 203–218. https://doi.org/10.1242/jcs.188102
Funding
This work was supported by the Russian Science Foundation (project no. 17-74-20161).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.
Additional information
Translated by M. Batrukova
Rights and permissions
About this article
Cite this article
Bychkov, M.L., Shulepko, M.A., Shlepova, O.V. et al. Recombinant Analogue of the Human Protein SLURP-1 Inhibits the Growth of Multicellular Spheroids Reconstructed from Carcinoma Cells. Dokl Biochem Biophys 489, 392–395 (2019). https://doi.org/10.1134/S1607672919060103
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1607672919060103